Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Furoate Nasal Spray in Seasonal Allergic Rhinitis
NCT00468312Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 2007
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of mometasone furoate nasal spray in seasonal allergic rhinitis (SAR) (2 arms), sponsored by Organon & Co. Primary endpoints: Total Nasal Symptom Score and Total Ocular Symptom Score. Started Mar 2007; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00468312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00468312.